Pyrimidine Antagonist

general

Centers

Active Trials

$12.5B

Cancer Funding

Specific Cancer Types(1)

Name	Centers	Active Trials
Gemcitabine	48	—

Top Centers for Pyrimidine Antagonist(48)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Active Trials	Cancer Funding	Score
1	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive	—	$911M	—
2	UCSF Helen Diller Family Comprehensive Cancer CenterSan Francisco, CA NCI Comprehensive	—	$831M	—
3	Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive	—	$827M	—
4	University of Michigan Rogel Cancer CenterAnn Arbor, MI NCI Comprehensive	—	$662M	—
5	Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive	—	$655M	—
6	UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive	—	$569M	—
7	UPMC Hillman Cancer CenterPittsburgh, PA NCI Comprehensive	—	$543M	—
8	Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive	—	$534M	—
9	Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive	—	$509M	—
10	Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive	—	$507M	—
11	The University of Texas MD Anderson Cancer CenterHouston, TX NCI Comprehensive	—	$472M	—
12	The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL NCI Comprehensive	—	$452M	—
13	The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive	—	$370M	—
14	University of Colorado Cancer CenterAurora, CO NCI Comprehensive	—	$319M	—
15	Moffitt Cancer CenterTampa, FL NCI Comprehensive	—	$296M	—
16	O’Neal Comprehensive Cancer Center at the University of Alabama at BirminghamBirmingham, AL NCI Comprehensive	—	$291M	—
17	Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive	—	$262M	—
18	UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive	—	$227M	—
19	Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive	—	$223M	—
20	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive	—	$222M	—
21	Indiana University Melvin and Bren Simon Comprehensive Cancer CenterIndianapolis, IN NCI Comprehensive	—	$216M	—
22	Sylvester Comprehensive Cancer CenterMiami, FL NCI Clinical	—	$194M	—
23	Hollings Cancer CenterCharleston, SC NCI Clinical	—	$187M	—
24	The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive	—	$186M	—
25	UCI Chao Family Comprehensive Cancer CenterOrange, CA NCI Comprehensive	—	$185M	—
26	Medical College of Wisconsin Cancer CenterMilwaukee, WI	—	$181M	—
27	Wilmot Cancer Institute, UR MedicineRochester, NY NCI Clinical	—	$153M	—
28	Cleveland Clinic Cancer CenterCleveland, OH	—	$150M	—
29	Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical	—	$143M	—
30	Stephenson Cancer CenterOklahoma City, OK NCI Clinical	—	$130M	—
31	University of Illinois Cancer CenterChicago, IL	—	$122M	—
32	Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive	—	$103M	—
33	Salk Institute Cancer CenterLa Jolla, CA NCI Basic_laboratory	—	$99M	—
34	Boston University Cancer CenterBoston, MA	—	$98M	—
35	Karmanos Cancer InstituteDetroit, MI NCI Comprehensive	—	$94M	—
36	Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX	—	$83M	—
37	Cancer Center at IllinoisUrbana, IL	—	$81M	—
38	Stony Brook Cancer CenterStony Brook, NY	—	$79M	—
39	University of Cincinnati Cancer CenterCincinnati, OH	—	$71M	—
40	Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL	—	$59M	—
41	UofL James Graham Brown Cancer CenterLouisville, KY	—	$59M	—
42	Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ	—	$58M	—
43	Georgia Cancer Center, Augusta UniversityAugusta, GA	—	$53M	—
44	Upstate Cancer CenterSyracuse, NY	—	$15M	—
45	University of Texas Medical Branch Cancer CenterGalveston, TX	—	$15M	—
46	Princess Margaret Cancer CentreToronto, ON	—	—	—
47	Louisiana Cancer Research CenterNew Orleans, LA	—	—	—
48	Tampa General Hospital Cancer InstituteTampa, FL	—	—	—

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →